Literature DB >> 15166662

More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon.

Maartje van den Bos1, Mabel van den Hoven, Esther Jongejan, Femke van der Leij, Meta Michels, Sandra Schakenraad, Katja Aben, Nicoline Hoogerbrugge, Marjolijn Ligtenberg, J Han van Krieken.   

Abstract

PURPOSE: Recognition of hereditary nonpolyposis colorectal cancer (HNPCC)-related endometrial carcinoma from sporadic carcinoma by histologic features as compared with colonic cases. STUDY
DESIGN: Case-control study. METHODS AND MATERIALS: From the files of the Nijmegen Hereditary Cancer Clinic, HNPCC-related (n = 6) endometrial and colorectal (n = 18) carcinomas were selected. For every HNPCC-related tumor, 2 sporadic control cases were included. The tumors were evaluated for the following 7 pathologic features: tumor differentiation, T-stage, growth pattern, presence of Crohn-like lymphoid reaction, mucinous differentiation, presence of lymphangioinvasive growth, and the amount of tumor-infiltrating lymphocytes.
RESULTS: HNPCC-related endometrial carcinomas were significantly more often poorly differentiated (83% versus 27%), more often showed the presence of a Crohn-like lymphoid reaction (100% versus 13%) and lymphangioinvasive growth (67% versus 0%), and high number of tumor-infiltrating lymphocytes were more often present (100% versus 36%) compared with sporadic endometrial carcinomas. The differences between HNPCC and sporadic colorectal cancer specimens were less discriminating.
CONCLUSIONS: HNPCC-related endometrial carcinomas are characterized by poor differentiation, more frequent Crohn-like lymphoid reaction, lymphangioinvasive growth and more tumor-infiltrating lymphocytes. These features therefore might form the basis for selecting patients for counseling in a hereditary cancer clinic or testing for microsatellite instability or mutation analysis of mismatch repair genes, especially when they are of relatively young age.

Entities:  

Mesh:

Year:  2004        PMID: 15166662     DOI: 10.1097/01.pas.0000126720.49083.11

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers.

Authors:  Aung Ko Win; James G Dowty; Yoland C Antill; Dallas R English; John A Baron; Joanne P Young; Graham G Giles; Melissa C Southey; Ingrid Winship; Lara Lipton; Susan Parry; Stephen N Thibodeau; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Noralane M Lindor; Polly A Newcomb; John L Hopper; Mark A Jenkins
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

Review 2.  Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.

Authors:  Jinru Shia; Susanne Holck; Giovanni Depetris; Joel K Greenson; David S Klimstra
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 3.  Gynecologic Cancers in Lynch Syndrome/HNPCC.

Authors:  Karen H Lu; Russell R Broaddus
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer: identical germline mutations associated with variable tumour morphology and immunohistochemical expression.

Authors:  Britta Halvarsson; Wolfram Müller; Maria Planck; Anna Clara Benoni; Peter Mangell; Johan Ottosson; Magnus Hallén; Anna Isinger; Mef Nilbert
Journal:  J Clin Pathol       Date:  2006-08-10       Impact factor: 3.411

5.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Authors:  Robert M W Hofstra; Amanda B Spurdle; Diana Eccles; William D Foulkes; Niels de Wind; Nicoline Hoogerbrugge; Frans B L Hogervorst
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

6.  Lynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucins.

Authors:  Michael D Walsh; Margaret C Cummings; Sally-Ann Pearson; Mark Clendenning; Rhiannon J Walters; Belinda Nagler; John L Hopper; Mark A Jenkins; Graeme K Suthers; Jack Goldblatt; Kathy Tucker; Michael R Gattas; Julie L Arnold; Susan Parry; Finlay A Macrae; Michael A McGuckin; Joanne P Young; Daniel D Buchanan
Journal:  Mod Pathol       Date:  2013-02-01       Impact factor: 7.842

7.  Clinicopathological features and management of cancers in lynch syndrome.

Authors:  Markku Aarnio
Journal:  Patholog Res Int       Date:  2012-04-30

8.  Hysteroscopic findings in women at risk of HNPCC. Results of a prospective observational study.

Authors:  Fabrice Lécuru; Ulrike Metzger; Catherine Scarabin; Marie Aude Le Frère Belda; Sylviane Olschwang; Pierre Laurent Puig
Journal:  Fam Cancer       Date:  2007-04-06       Impact factor: 2.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.